Is Participating in a Clinical Trial Right for You?

Our Goal

Our goal is to provide information that might help you decide whether or not to take part in a clinical trial. This handout reviews key information to consider and contains additional questions that you may want to ask.

We hope that this information is useful as you consider whether or not a clinical trial is right for you.

What is a Clinical Trial?

A clinical trial is a research study that is done to answer important questions about medical care. They are research studies in which new therapies and treatments are tested in patients to determine if they are safe and effective. If you choose to take part, you and the study team will work together to find out if a new method of treatment, diagnosis, or prevention is effective. Carefully conducted clinical trials are the safest and fastest way to find treatments that work in people, and new ways to improve health.

There are different kinds of clinical trials:

Clinical trials are conducted in phases. Usually, they compare a new product or therapy to something else to see if it works as well or better to treat or prevent a disease or condition. In a blinded study, a participant may be randomly assigned to receive the test product, or an existing, approved therapy. In some studies, participants may be assigned to receive a placebo (a product with no therapeutic action that looks like the test product). Comparison with a placebo can be the fastest and surest way to demonstrate therapeutic effectiveness of new products. However, placebos are not used where a patient would be put at risk, particularly in the study of treatments for serious illnesses, by not having effective therapy.

Participating in well-designed and well-executed clinical trials is one approach for eligible patients/volunteers to:

Taking part in a clinical trial is voluntary. Anyone can decide not to participate. If you decide to take part in a trial and then change your mind, you can also drop out of the trial at any time. Whatever decision you make, your doctors and nurses will make sure you get the best care possible for you.

top of page
Return to Top of Page

How Are Patients Protected While on a Study?

There are three systems in place to keep patients as safe as possible while taking part in a study: protocol review, eligibility, and monitoring.

Protocol Review

When a researcher wants to perform a clinical trial, he or she must prepare a detailed plan. This is called a protocol. The trial cannot be started until a formal committee people, called the Institutional Review Board (IRB) has reviewed the protocol for safety and effectiveness. The IRB are made up of physicians, nurses, scientists, pharmacists, administrators who may work at the facility offering the trial, and at least one person who is not connected with the health care facility.

Federal institutions such as the U.S. Food and Drug Administration (FDA) or the National Cancer Institute (NCI) may also review the study. While the study is going on, the IRB receives regular updates to make sure the study is being carried out as planned and that any safety issues are addressed promptly.

Like all clinical research, each clinical trial must be based on the following principals:

top of page
Return to Top of Page

Eligibility, or Do You Fit the Group of People to be Studied?

A patient must meet certain requirements to take part in a clinical trial. First, if your risk from being in the trial is greater than any possible benefit, you might not be able to join the study. Second, the people taking part in some trials must be similar to one another so the study team can learn if the new treatment works the same as or better than the standard treatment. Some examples of study criteria are age, disease type, the ability of body organs to work, and the ability of the person to carry out the normal activities of daily living.

top of page
Return to Top of Page

Safety Monitoring, or How Will Side Effects be Found Early?

Often, the study treatment has not been used in many people. In these cases it may be hard to predict what side effects might occur. During a study, the team will try to identify any potential side effects as quickly as possible. They may do more tests and physical exams than they would if someone were not taking part in a clinical trial. You would be informed to report any potential side-effects, even minor ones, quickly to receive the extra care provided during a clinical trial. If you develop unexpected health problems, you would be treated promptly and may have to withdraw from the study.

top of page
Return to Top of Page

What are the Phases of Clinical Trials?

Phase I: How much of the new treatment can be given with reasonable safety?

The goal of a Phase I study is to find out three things:

Researchers test an experimental drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects. Generally, if you are one of the first patients to take part in a Phase I study, you will be given a small amount of the drug. This amount is based on animal testing or the safe dose of a similar medication given to other people. In some cases, it is based on the safe dose of the new drug given to people who took part in earlier studies of the drug. If there are no serious side effects, people who enroll later in the same study will receive more of the drug, until the study team learns the maximum amount of the drug that can be given and still be reasonably safe. The studies are most often carried out at academic medical centers or large hospitals.

Phase II: Does the new treatment work for a specific type of disease or condition?

The goals of a Phase II study are to:

In Phase II studies, the experimental study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety. Patients with a specific disease or condition are given the highest dose of the new drug that is thought to be reasonably safe. This dose is based on results from Phase I studies. Generally, these studies are often carried out at major hospitals or academic medical centers, but they may also be conducted at local community hospitals.

Phase III: Is the new treatment better than standard treatment for a specific disease or condition?

In Phase III, the experimental study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the experimental drug or treatment to be used safely. Patients are assigned at random to a group that receives standard treatment or to a group that receives the new treatment. This means that the patient is assigned to a group by chance, like rolling dice or flipping a coin, and not by his or her doctor. The patient has an equal chance of being assigned to any one of the groups. If the study team learns that one of the drugs is not effective or is too toxic, the study might be changed or stopped earlier than planned.

Phase IV trials are conducted after a drug or device has been approved for consumer sale and often called post marketing studies.

Phase IV trials help: (1) to compare a drug with other drugs already in the market; (2) to monitor a drug's long-term effectiveness and impact on a patient's quality of life; and (3) to determine the cost-effectiveness of a drug therapy relative to other traditional and new therapies. Phase IV studies can result in a drug or device being taken off the market or restrictions of use could be placed on the product depending on the findings in the study.

top of page
Return to Top of Page

What Might Help You Decide if Entering a Clinical Trial is Right for You?

If you are eligible and are thinking about taking part in a study, it is important that you find out what options are available and that you think about them carefully. Don’t make a decision without getting as much information as you reasonably can.

Understand your choices.

Bring a trusted family member or friend with you when you meet with the study team to discuss options. That person can:

Meet with a financial counselor at the study site.

He or she can contact your insurance company to find out if it will pay for the extra costs of taking part in the trial. Many insurance companies will pay for a lot of clinical trial-related services.

Request a professional medical interpreter if English is not your first language.

That person will:

Never feel pressured to participate.

If you are feeling pressured by anyone, even a family member, to make a certain decision, you may always discuss your options with someone else. Possible sources of help include:

Remember that you don’t have to take part in research. You should not take part in the trial unless you feel it is right for you.

Questions You Might Ask the Study Team or Hospital Staff

Questions You Might Ask Yourself

Because each person is unique, what feels right to someone else might not feel right to you. In other words, when it comes to a clinical trial, you should make a decision based on your personal feelings and needs. Below is a list of questions you might want to ask yourself as you think about whether or not to take part in a clinical trial.

top of page
Return to Top of Page

 

Copyright ©2013, Rutgers, The State University of New Jersey, an equal opportunity, affirmative action institution.